Protein

Recombinant Human Carbohydrate antigen 125 (CA125) Protein

  • Cat. No.:AP50142HU
  • Name:Recombinant Human Carbohydrate antigen 125 (CA125) Protein
Cat. No. Size Price


AP50142HU 100μg 380
AP50142HU 500μg 1140
PubMed Product Details
Technical Data

Species Reactivity

Human

Source

Prokaryotic expression

Host

E. coli

Synonyms

CA125; MUC16; MUC-16

Concentration

1 mg/mL

Form

Lyophilized or Liquid

Purity

> 90% as determined by SDS-PAGE

Residues

Q8WXI7

Tag

N-terminal His-tag

Purification

Affinity purification

Molecular Weight(MW)

11 kDa

Applications

Western blotting,ELISA;SDS-PAGE;Antigen; Product Overview: CA-125 (cancer antigen 125, carcinoma antigen 125, or carbohydrate antigen 125) also known as mucin 16 or MUC16 is a protein that in humans is encoded by the MUC16 gene. MUC16 is a member of the mucin family glycoproteins. CA-125 has found application as a tumor marker or biomarker that may be elevated in the blood of some patients with specific types of cancers, or other benign conditions. Mucin 16 is a membrane associated mucin that possesses a single transmembrane domain. A unique property of MUC16 is its large size. MUC16 is more than twice as long as MUC1 and MUC4 and contains about 22,000 amino acids, making it the largest membrane associated mucin.
Usage: Reconstitute in PBS or others.
Stability: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Storage: Store it under sterile conditions at -80°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles. Samples are stable for up to twelve months from date of receipt at -80℃.
Stroage Buffer: Lyophilized from 50mM Tris-cl,0.5mM EDTA ,300mM NaCl,pH 9.0
Precautions: This product is for research use only, not for diagnostic or therapeutic use.
Summary

Research topic

Bone and cartilage metabolism

Summary

Vitamin D is mainly synthesized in the skin from 7-dehydrocholesterol and is partially from dietary and supplementation origin. In the liver, Vitamin D is hydroxylated on carbon 25 to produce the intermediate 25OH Vitamin D. 25OH Vitamin D is further metabolized before it can carry out the functions of Vitamin D on intestine, kidneys, bone and other organs and tissues. This subsequent reaction takes place in the kidneys and in other tissues. Thus 25OH Vitamin D is further hydroxylated in the 1α-position to produce 1α,25-dihydroxyvitamin D (1,25(OH)2 Vitamin D). In addition to the above-mentioned tissues, placenta of pregnant women and macrophage cells in case of sarcoidis can also produce some amount of 1,25(OH)2 Vitamin D. 1,25(OH)2 Vitamin D is the active form of Vitamin D with regard to the known functions whereas 25OH Vitamin D and Vitamin D itself can be excluded as being physiologically functional. 1,25(OH)2 Vitamin D stimulates the intestinal absorption of both calcium and phosphorus. It also stimulates bone resorption and mineralization thereby preventing the development of rickets and osteomalacia. 1,25(OH)2 Vitamin D is also be active in other tissues responsible for Calcium transport (placenta, kidney, mammary gland,…) and endocrine glands such as parathyroid glands. 1,25(OH)2 Vitamin D is rapidly metabolized and its halflife is approximately 12h in plasma. Its main metabolite is calcitroic acid, a C-23 carboxylic derivative, essentially without any biological activity. In addition to this pathway, 1,25(OH)2 Vitamin D undergoes 24-hydroxylation to produce 1,24,25-trihydroxyvitamin D. This compound has less biological activity than its parent and this metabolic route is considered as a minor pathway. The levels of 1,25(OH)2 Vitamin D in plasma or serum is 100 to 1000 less than that of 25OH Vitamin D. Due to its low concentrations and the presence of many similar metabolites, the measurement of 1,25(OH)2 Vitamin D requires extraction and separation by chromatography.

Product References (1)

References

  • Parfieniuk-Kowerda A, Świderska M, Rogalska M, Maciaszek M, Jaroszewicz J,Flisiak R. Chronic hepatitis B virus infection is associated with decreased serum25(OH)D concentration in non-cirrhotic patients. Clin Exp Hepatol. 2019Mar;5(1):75-80. doi: 10.5114/ceh.2019.83160. Epub 2019 Feb 20. PubMed PMID:30915410; PubMed Central PMCID: PMC6431090. See more on PubMed
Summary References (1)

References to 1,25OH2 Vitamin D

  • Bouillon RA, Auwerx JH, Lissens WD, Pelemans WK. Vitamin D status in the elderly: seasonal substrate deficiency causes 1,25-dihydroxycholecalciferol deficiency. Am J Clin Nutr. 1987 Apr;45 (4):755-63
Related Products Docs
COMPANY INTRODUCTION
——
Companies always with integrity, innovation, professional, service to win the trust of customers, we will abide by the integrity
management, intentions services, to create value for customers!

COMPANY INTRODUCTION
——
Full Contact Info
          xxx@.co.m
          020-000000 400-000000

Service case
——
HOME             FASHIONS             TREND               BRAND              JEANS